Skip to main content

Advertisement

SpringerLink
Log in

GATA3 Immunohistochemical Expression in Salivary Gland Neoplasms

  • Original Paper
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

GATA3 is a zinc finger transcription factor that regulates the normal development of many tissues and cell types. Recent studies have shown that immunohistochemical nuclear staining for GATA3 among tumors is highly restricted to carcinomas of breast and urothelial origin; however salivary gland tumors have not been tested. Given that breast and salivary gland tissues are very similar with respect to embryologic development and structure, we performed GATA3 staining on a spectrum of salivary gland neoplasms. GATA3 immunohistochemistry was performed on a diverse collection of 180 benign and malignant salivary gland neoplasms including 10 acinic cell carcinomas, 2 adenocarcinomas not otherwise specified, 41 adenoid cystic carcinomas, 2 epithelial-myoepithelial carcinomas, 1 low grade cribriform cystadenocarcinoma, 15 mammary analogue secretory carcinomas, 7 metastatic squamous cell carcinomas, 27 mucoepidermoid carcinomas, 2 oncocytic carcinomas, 5 oncocytomas, 34 pleomorphic adenomas, 4 polymorphous low grade adenocarcinomas, 25 salivary duct carcinomas, and 5 Warthin tumors. Staining for GATA3 was observed in 92/180 (51 %) of salivary gland tumors. GATA3 staining was observed in most of the tumor types, but diffuse immunolabeling was consistently seen in salivary duct carcinoma (25 of 25) and mammary analogue secretory carcinoma (15 of 15)—the two tumor types that most closely resemble breast neoplasia. Background benign salivary gland tissue was also usually weakly positive in both acini and ducts. GATA3 immunostaining is not restricted to tumors of breast and urothelial origin. Rather, it is expressed across many different types of salivary gland neoplasms. As a result, salivary gland origin should be considered in the differential diagnosis of a GATA3-positive carcinoma, particularly in the head and neck. Although GATA3 immunohistochemistry is not helpful in resolving the differential diagnosis between a primary salivary gland neoplasm and metastatic breast cancer, it may have some utility in subtyping salivary gland tumors, particularly salivary duct carcinoma and mammary analogue secretory carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kouros-Mehr H, Slorach EM, Sternlicht MD, et al. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell. 2006;127:1041–55.

    Article  PubMed  CAS  Google Scholar 

  2. Asselin-Labat ML, Sutherland KD, Barker H, et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol. 2007;9:201–9.

    Article  PubMed  CAS  Google Scholar 

  3. Hendriks RW, Nawijn MC, Engel JD, et al. Expression of the transcription factor GATA-3 is required for the development of the earliest T cell progenitors and correlates with stages of cellular proliferation in the thymus. Eur J Immunol. 1999;29:1912–8.

    Article  PubMed  CAS  Google Scholar 

  4. Grote D, Souabni A, Busslinger M, et al. Pax 2/8-regulated Gata 3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney. Development. 2006;133:53–61.

    Article  PubMed  CAS  Google Scholar 

  5. Labastie MC, Catala M, Gregoire JM, et al. The GATA-3 gene is expressed during human kidney embryogenesis. Kidney Int. 1995;47:1597–603.

    Article  PubMed  CAS  Google Scholar 

  6. Tsarovina K, Pattyn A, Stubbusch J, et al. Essential role of Gata transcription factors in sympathetic neuron development. Development. 2004;131:4775–86.

    Article  PubMed  CAS  Google Scholar 

  7. Kaufman CK, Zhou P, Pasolli HA, et al. GATA-3: an unexpected regulator of cell lineage determination in skin. Genes Dev. 2003;17:2108–22.

    Article  PubMed  CAS  Google Scholar 

  8. Liu H, Shi J, Wilkerson ML, et al. Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. Am J Clin Pathol. 2012;138:57–64.

    Article  PubMed  Google Scholar 

  9. Higgins JP, Kaygusuz G, Wang L, et al. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Am J Surg Pathol. 2007;31:673–80.

    Article  PubMed  Google Scholar 

  10. Yang M, Nonaka D. A study of immunohistochemical differential expression in pulmonary and mammary carcinomas. Mod Pathol. 2010;23:654–61.

    Article  PubMed  CAS  Google Scholar 

  11. Chang A, Amin A, Gabrielson E, et al. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung. Am J Surg Pathol. 2012;36:1472–6.

    Article  PubMed  Google Scholar 

  12. Gruver AM, Amin MB, Luthringer DJ, et al. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung. Arch Pathol Lab Med. 2012;136:1339–46.

    Article  PubMed  Google Scholar 

  13. Skalova A, Vanecek T, Sima R, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34:599–608.

    PubMed  Google Scholar 

  14. Bishop JA, et al. Cytopathologic features of mammary analogue secretory carcinoma. Cancer Cytopathol. 2012. doi:10.1002/cncy.21245.

  15. Bishop JA, Yonescu R, Batista D, Eisele DW, et al. Most non-parotid “acinic cell carcinomas” represent mammary analoge secretory carcinomas. Am J Surg Pathol. 2013;In Press.

  16. Engelsen IB, Stefansson IM, Akslen LA, et al. GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival. Am J Obstet Gynecol. 2008; 199: 543 e541–547.

    Google Scholar 

  17. Wick MR, Ockner DM, Mills SE, et al. Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma. Am J Clin Pathol. 1998;109:75–84.

    PubMed  CAS  Google Scholar 

  18. Swanson PE, Pettinato G, Lillemoe TJ, et al. Gross cystic disease fluid protein-15 in salivary gland tumors. Arch Pathol Lab Med. 1991;115:158–63.

    PubMed  CAS  Google Scholar 

  19. Wick MR, Lillemoe TJ, Copland GT, Swanson PE, Manivel JC, Kiang DT. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol. 1989;20:281–7.

    Article  PubMed  CAS  Google Scholar 

  20. Ellis GL, Auclair PL. Salivary duct carcinoma. AFIP atlas of tumor pathology: tumors of the salivary glands. Washington, D.C.: ARP Press, 2008:322–332.

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, The Johns Hopkins University School of Medicine, 401 N. Broadway, Weinberg 2249, Baltimore, MD, 21231, USA

    Lauren E. Schwartz, Shahnaz Begum, William H. Westra & Justin A. Bishop

  2. Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins Medical Institutions, Baltimore, MD, USA

    William H. Westra

  3. Department of Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA

    William H. Westra

Authors
  1. Lauren E. Schwartz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shahnaz Begum
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. William H. Westra
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Justin A. Bishop
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lauren E. Schwartz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schwartz, L.E., Begum, S., Westra, W.H. et al. GATA3 Immunohistochemical Expression in Salivary Gland Neoplasms. Head and Neck Pathol 7, 311–315 (2013). https://doi.org/10.1007/s12105-013-0442-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-013-0442-3

Keywords

Search

Navigation